Biomimetic Multilayer Blood Vessel via PVA Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing artificial blood vessel grafts, particularly those made from polylactic acid (PLA) using 3D printing, lack flexibility to regulate blood flow and do not possess optimal porosity for nutrition and oxygen exchange, making them inadequate for mimicking the mechanical and biological properties of native blood vessels.
Innovation Solution
A method involving the production of biomimetic flexible multilayer blood vessels through 3D printing, where an elastic outer layer is created using a biodegradable elastomer and human induced pluripotent stem cell-derived smooth muscle and endothelial cells are formed into gels with fibrinogen and thrombin, with the outer layer's polyvinyl alcohol component removed to enhance elasticity and porosity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If 3D printing is used to fabricate artificial blood vessels from rigid materials like PLA, then manufacturing precision and structural integrity are improved, but flexibility and porosity deteriorate
Solution Approach 1:
The patent employs a multilayer composite structure consisting of an inner layer (fibrinogen-thrombin gel with endothelial cells), middle layer (fibrinogen-thrombin gel with smooth muscle cells), and outer layer (biodegradable elastomer with polyvinyl alcohol). This composite approach combines the advantages of different materials: the rigid fibrinogen-thrombin gel provides structural integrity and manufacturing precision, while the biodegradable elastomer outer layer contributes flexibility and elasticity. The synergistic combination resolves the contradiction between structural integrity and flexibility.
Solution Approach 2:
The patent utilizes porous fibrinogen-thrombin hydrogel matrices in the inner and middle layers, which naturally exhibit high porosity for nutrient and oxygen exchange. The porous structure is inherent to the hydrogel material system, allowing blood cells and nutrients to penetrate through the vessel wall. This resolves the contradiction between structural integrity and porosity, as the hydrogel framework maintains structural coherence while providing extensive porous pathways for biological exchange.
2Adaptability or versatility
If polyvinyl alcohol is removed from the outer layer, then porosity and elasticity are improved, but manufacturing complexity increases
Solution Approach 1:
The patent incorporates polyvinyl alcohol (PVA) as a sacrificial component during the 3D printing fabrication process. The PVA is pre-integrated into the outer layer structure, and its removal is performed as a preliminary processing step before biological implantation. This preliminary removal action creates the desired porous structure in advance, eliminating the need for complex post-implantation modifications and simplifying the overall manufacturing workflow despite the additional initial step.
Solution Approach 2:
The patent employs extraction of the polyvinyl alcohol component from the outer layer to create porosity. The PVA is selectively removed through dissolution or degradation, leaving behind a porous network structure. This extraction approach allows precise control over pore formation without requiring complex manufacturing processes, as the porosity is generated by removing a specific component rather than building it in from scratch.
3Reliability
If multilayer structure with cell gels is formed, then biological functionality is improved, but ease of manufacture deteriorates
Solution Approach 1:
The patent divides the blood vessel into three distinct functional layers: an inner layer with endothelial cells for blood contact, a middle layer with smooth muscle cells for contraction, and an outer layer with elastomer for structural support. Each layer is fabricated separately with its specific cell type and matrix composition, then assembled into a multilayer structure. This segmentation allows optimized biological functionality for each layer while enabling modular manufacturing, where each layer can be prepared independently using standardized protocols.
Solution Approach 2:
The patent uses a universal fibrinogen-thrombin gelation system for both the inner and middle layers, despite their different cell populations. This universal crosslinking mechanism simplifies manufacturing by allowing the same basic material system and gelation protocol to be applied across multiple layers, reducing the complexity that would arise from using entirely different material systems for each layer. The multi-functionality of the fibrinogen-thrombin system supports both structural integrity and cell encapsulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting blood vessels exhibit superior flexibility, durability, and porosity, capable of withstanding high blood pressure and facilitating physiological functions like vasodilation and vasoconstriction, while also supporting cell proliferation and biodegradability, thus mimicking native blood vessels effectively.
Implementation Method 1
human induced pluripotent stem cell-derived smooth muscle cells are mixed with fibrinogen solution and extruded with thrombin to form a smooth muscle cell gel, and forming a second inner layer comprised of human induced pluripotent stem cell-derived endothelial cells, wherein the human induced pluripotent stem cell-derived endothelial cells are mixed with fibrinogen solution and extruded with thrombin to form an endothelial cell gel
Implementation Method 2
the polyvinyl alcohol is removed by immersing the elastic outer layer in deionized water
Data Source
AI summary
Systems and methods for producing artificial blood vessels. In certain embodiments, the method for producing blood vessels includes printing an elastic outer layer and removing polyvinyl alcohol component from the elastic outer layer. The process then involves forming a first inner layer of smooth muscle cells, wherein the smooth muscle cells are mixed with 5 fibrinogen solution and extruded with thrombin to form a smooth muscle cell gel, and forming a second inner layer of endothelial cells, wherein the endothelial cells are mixed with fibrinogen solution and extruded with thrombin to form an endothelial cell gel.